市場調查報告書
商品編碼
1494612
輸液袋市場:按解決方案類型、材料、產能、技術、應用、最終用戶 - 2024-2030 年全球預測Infusion Bags Market by Type of Solution (Antibiotics, Chemotherapy Solutions, Intravenous (IV) Fluids), Material (Polyethylene, Polypropylene, Polyvinyl Chloride), Capacity, Technology, Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年輸液袋市場規模為52.7億美元,預計2024年將達56.2億美元,2030年將達到83.9億美元,複合年成長率為6.86%。
輸液 (IV) 袋包括用於向患者靜脈注射液體、藥物和營養物質的軟性無菌容器。這些袋子由 PVC、聚烯和其他生物相容性塑膠等材料製成,具有破損風險低、易於運輸和儲存等優點。市場分析的範圍包括對各種袋類型的研究,例如單室、多室以及從小到大不同容量的其他袋類型。它也針對醫院、診所、居家醫療機構和門診手術中心等部門。由於全球慢性疾病的增加,對靜脈輸液 (IV) 袋的需求不斷增加。不斷完善的醫療基礎設施導致人們越來越偏好一次性輸液產品,而一次性輸液產品構成了輸液袋的基礎。家庭醫療保健服務的日益普及進一步刺激了市場成長。與輸液治療相關的污染和感染風險阻礙了市場成長。
主要市場統計 | |
---|---|
基準年[2023] | 52.7億美元 |
預測年份 [2024] | 56.2億美元 |
預測年份 [2030] | 83.9億美元 |
複合年成長率(%) | 6.86% |
輸液治療技術的不斷進步以及環保和生物分解性輸液袋的市場開拓預計將為市場成長創造機會。整合安全功能和即時監控的智慧輸液系統的不斷進步預計將擴大市場成長。
區域洞察
在美洲,對高品質醫療保健服務的需求不斷增加,輸液袋市場也不斷擴大。在美洲,慢性病盛行率的增加和強大的醫療基礎設施正在推動輸液袋市場的成長。先進技術和醫療保健領域的大量投資正在推動創新輸液袋產品的發展。高度的消費者意識和嚴格的 FDA 法規確保我們的產品符合安全性和有效性標準。在南美洲,發達的公共衛生保健系統和人口老化導致輸液袋的需求增加。歐盟 (EU) 國家擁有完善且嚴格監管的醫療保健產業。不斷成長的老年人口和以患者為中心的醫療保健政策正在推動該地區對輸液袋的需求。由於環保意識的增強和歐盟嚴格的醫療設備法規,歐盟消費者對環保、高品質的醫療設備表現出強烈的需求。研究和開發方面的投資促使一些公司開發了生物分解性的輸液袋並獲得了專利。歐盟市場注重永續性和病人安全,正在採用先進的給藥系統和智慧輸液技術。隨著醫療基礎設施投資的增加,中東和非洲輸液袋市場正在興起,特別是在波灣合作理事會(GCC)國家。亞太地區的輸液袋市場充滿活力且快速成長,以中國、日本和印度為主導。亞太地區人口眾多,政府改善醫療服務的努力正在增加對輸液袋的需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估輸液袋市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對輸液袋市場供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對輸液袋市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[198 Pages Report] The Infusion Bags Market size was estimated at USD 5.27 billion in 2023 and expected to reach USD 5.62 billion in 2024, at a CAGR 6.86% to reach USD 8.39 billion by 2030.
Infusion (IV) bags encompass flexible, sterile containers used for the intravenous administration of fluids, medications, and nutritional substances to patients. These bags are made from materials such as PVC, polyolefin, and other biocompatible plastics, offering advantages such as lower risk of breakage and ease of transportation and storage. The scope of the market analysis includes an examination of various bag types, such as single-chamber, multi-chamber, and others, for different volumes ranging from small to large capacity. It covers sectors such as hospitals, clinics, home care settings, and ambulatory surgical centers. The rise in chronic diseases worldwide expands the need for Infusion (IV) bags. The increasing preference for single-use, disposable infusion products with constant improvements in healthcare infrastructure is creating a platform for infusion bags. The growing adoption of home healthcare services further stimulates market growth. The risk of contamination and infection associated with infusion therapies hampers the market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.27 billion |
Estimated Year [2024] | USD 5.62 billion |
Forecast Year [2030] | USD 8.39 billion |
CAGR (%) | 6.86% |
Continuous technological advancements in infusion therapies and the development of eco-friendly, biodegradable infusion bags are anticipated to create opportunities for market growth. Rising advancements in smart infusion systems integrated with safety features and real-time monitoring are expected to expand the market growth.
Regional Insights
In the Americas, the growing need for quality healthcare services extends to the market for infusion bags. In the Americas, the increasing prevalence of chronic diseases coupled with a strong healthcare infrastructure propels the growth of the infusion bags market. Advanced technologies and significant investments in the healthcare sector facilitate the development of innovative infusion bag products. High levels of consumer awareness and strict FDA regulations ensure that products meet safety and efficacy standards. In South America, a robust public healthcare system and an increasingly aging population contribute to the rise in demand for infusion bags. European Union (EU) countries have a well-established and heavily regulated healthcare sector. The increase in the geriatric population and patient-centric healthcare policies drive the demand for infusion bags in this region. EU consumers exhibit a high need for eco-friendly and high-quality medical devices due to heightened environmental awareness and stringent EU medical device regulations. Investment in research has led to the development of biodegradable infusion bags, with some companies obtaining patents for the same. With a focus on sustainability and patient safety, the EU market is receptive to advanced drug delivery systems and smart infusion technologies. The market for infusion bags in the Middle East and Africa is emerging with increased investments in healthcare infrastructure, particularly in the Gulf Cooperation Council (GCC) countries. The Asia-Pacific region exhibits a dynamic and rapidly growing market for infusion bags, with countries including China, Japan, and India at the forefront. Asia-Pacific's large population base and government initiatives to improve healthcare services have led to an increased demand for infusion bags.
Market Insights
The market dynamics represent an ever-changing landscape of the Infusion Bags Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Bags Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Bags Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Amneal Launched 39 New Retail and Injectable Products in 2023
Amneal Pharmaceuticals, Inc. significantly expanded its product catalog with the introduction of 39 new medicines in 2023. Amneal debuted 13 products, of which five are injectables, augmenting its presence in the infusion bag market. [Published On: 2024-01-04]
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
Baxter International Inc. announced the successful completion of the inaugural phase of its innovative IV bag recycling initiative. In partnership with Northwestern Medicine, the pioneering pilot program has effectively diverted over six tons of polyvinyl chloride (PVC) IV bag waste from landfills, advocating for environmental responsibility in the medical sector. [Published On: 2023-12-13]
Local Infusion Raises USD 10 Million in Series A Funding
Local Infusion, an innovative Nashville-based provider of tech-enabled infusion bag services, secured USD 10M in a Series A funding round guided by Blisce, with Meridian Street Capital and current investors contributing as well. This substantial investment will fuel the company's strategic growth plans, including opening 16 new centers across four states in the Northeastern United States. [Published On: 2023-11-30]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Bags Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Bags Market, highlighting leading vendors and their innovative profiles. These include Alfa Laboratories, APG Europe, B. Braun SE, Baxter international Inc., Becton, Dickinson and Company, Biometrix Corporation, CellBios Healthcare & Lifesciences Pvt. Ltd., Fairmont Medica, Fresenius Kabi, Hospira by Pfizer Inc., ICU Medical Inc., Kraton Corporation, LyondellBasell Industries Holdings B.V., Medicopack A/S, Mitra Industries Private Limited, Nipro Corporation, Otsuka Pharmaceutical Co., Ltd., Poly Medicure Ltd., Polycine GmbH, Qosina Corporation, RAUMEDIC AG, RENOLIT SE, Simulab Corporation, Technoflex S.A, Terumo Corporation, The Dow Chemical Company, The Metrix Company, and Unimedix Medical Equipments LLP.
Market Segmentation & Coverage
TA